Search

Your search keyword '"Benning, Louise"' showing total 7 results
Start Over Author "Benning, Louise" Publisher mdpi ag
7 results on '"Benning, Louise"'

1. BA.1/BA.5 Immunogenicity, Reactogenicity, and Disease Activity after COVID-19 Vaccination in Patients with ANCA-Associated Vasculitis: A Prospective Observational Cohort Study

Author

Speer, Claudius, primary, Töllner, Maximilian, additional, Benning, Louise, additional, Bartenschlager, Marie, additional, Kim, Heeyoung, additional, Nusshag, Christian, additional, Kälble, Florian, additional, Reineke, Marvin, additional, Reichel, Paula, additional, Schnitzler, Paul, additional, Zeier, Martin, additional, Morath, Christian, additional, Schmitt, Wilhelm, additional, Bergner, Raoul, additional, Bartenschlager, Ralf, additional, Lorenz, Hanns-Martin, additional, and Schaier, Matthias, additional

Published
2023
Full Text
View/download PDF

2. Liver-Support Therapies in Critical Illness—A Comparative Analysis of Procedural Characteristics and Safety

Author

Göth, Daniel, primary, Mahler, Christoph F., additional, Kälble, Florian, additional, Speer, Claudius, additional, Benning, Louise, additional, Schmitt, Felix C. F., additional, Dietrich, Maximilian, additional, Krautkrämer, Ellen, additional, Zeier, Martin, additional, Merle, Uta, additional, Morath, Christian, additional, Fiedler, Mascha O., additional, Weigand, Markus A., additional, and Nusshag, Christian, additional

Published
2023
Full Text
View/download PDF

3. Impaired Neutralizing Antibody Activity against B.1.617.2 (Delta) after Anti-SARS-CoV-2 Vaccination in Patients Receiving Anti-CD20 Therapy

Author

Töllner, Maximilian, primary, Speer, Claudius, additional, Benning, Louise, additional, Bartenschlager, Marie, additional, Nusshag, Christian, additional, Morath, Christian, additional, Zeier, Martin, additional, Süsal, Caner, additional, Schnitzler, Paul, additional, Schmitt, Wilhelm, additional, Bergner, Raoul, additional, Bartenschlager, Ralf, additional, Lorenz, Hanns-Martin, additional, and Schaier, Matthias, additional

Published
2022
Full Text
View/download PDF

4. Humoral Responses and Chronic GVHD Exacerbation after COVID-19 Vaccination Post Allogeneic Stem Cell Transplantation

Author

Pabst, Caroline, primary, Benning, Louise, additional, Liebers, Nora, additional, Janssen, Maike, additional, Caille, Leandra, additional, Speer, Claudius, additional, He, Lixiazi, additional, Schubert, Maria-Luisa, additional, Simons, Laura, additional, Hegenbart, Ute, additional, Schönland, Stefan, additional, Radujkovic, Aleksandar, additional, Schmitt, Michael, additional, Schnitzler, Paul, additional, Müller-Tidow, Carsten, additional, Dietrich, Sascha, additional, Dreger, Peter, additional, and Luft, Thomas, additional

Published
2022
Full Text
View/download PDF

5. Longitudinal Humoral Responses after COVID-19 Vaccination in Peritoneal and Hemodialysis Patients over Twelve Weeks

Author

Speer, Claudius, primary, Schaier, Matthias, additional, Nusshag, Christian, additional, Töllner, Maximilian, additional, Buylaert, Mirabel, additional, Kälble, Florian, additional, Reichel, Paula, additional, Grenz, Julia, additional, Süsal, Caner, additional, Zeier, Martin, additional, Schnitzler, Paul, additional, Morath, Christian, additional, Klein, Katrin, additional, and Benning, Louise, additional

Published
2021
Full Text
View/download PDF

6. Heterologous ChAdOx1 nCoV-19/BNT162b2 Prime-Boost Vaccination Induces Strong Humoral Responses among Health Care Workers

Author

Benning, Louise, primary, Töllner, Maximilian, additional, Hidmark, Asa, additional, Schaier, Matthias, additional, Nusshag, Christian, additional, Kälble, Florian, additional, Reichel, Paula, additional, Buylaert, Mirabel, additional, Grenz, Julia, additional, Ponath, Gerald, additional, Klein, Katrin, additional, Zeier, Martin, additional, Süsal, Caner, additional, Schnitzler, Paul, additional, Morath, Christian, additional, and Speer, Claudius, additional

Published
2021
Full Text
View/download PDF

7. Durability of Humoral Responses after an Adapted SARS-CoV-2 mRNA Vaccine Dose in Hemodialysis Patients.

Author

Benning L, Bartenschlager M, Kim H, Morath C, Zeier M, Schnitzler P, Bartenschlager R, and Speer C

Abstract

We recently showed that an adapted SARS-CoV-2 vaccine with wildtype and BA.4/BA.5 Omicron subtype epitopes induced a broad short-term immune response in hemodialysis patients. Antibodies with protective capacity were boosted significantly after a follow-up period of 3 weeks following a fifth vaccine dose. However, data on the longevity of the humoral response after bivalent vaccination are lacking but urgently needed to make recommendations for further booster vaccinations in this patient group. This study is an extension of our previously published data including 40 patients on hemodialysis with a follow-up period of 12 months after an adapted booster vaccine dose. We performed a detailed characterization of humoral immune responses and assessed breakthrough infections. In addition, the severity of breakthrough infections was assessed using an established grading system. Anti-S1 IgG and surrogate neutralizing antibodies significantly decreased during the period of 12 months ( p < 0.01 and p < 0.001, respectively). Live-virus neutralizing antibodies against the wildtype and the BA.5 subtype also significantly decreased over time ( p < 0.01 and p < 0.01, respectively). However, even 12 months after administration of the adapted vaccine dose, all 40/40 (100%) of hemodialysis patients showed detectable SARS-CoV-2 wildtype neutralization activity, with 35/40 (88%) also exhibiting detectable BA.5 subtype neutralization activity. During follow-up, 13/40 (33%) patients contracted a SARS-CoV-2 breakthrough infection, among which 12 cases were categorized as asymptomatic or mild, while only 1 case was classified as moderate disease activity. Thus, bivalent booster vaccination seems to induce a sustained immune response in hemodialysis patients over a period of 12 months with breakthrough infections occurring frequently but predominantly manifesting as asymptomatic or mild.

Published
2024
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results